Search results for "security"
Article
Applications of Surface Plasmon Resonance for Detection of Bispecific Antibody Activity
Surface plasmon resonance is helping define bispecific antibodies, the next-generation of biopharma therapeutics.
By Robert Karlsson
Abstract
Biotherapeutic antibodies are still the larg…
Article
Supply Chain Challenges for Single-Use Systems
In addition to shorter lead times, end-users can carry less inventory and have an enhanced level of supply security, with the ability to source their assemblies from multiple manufacturing sites.
…
Article
Optimizing Late-Stage and Commercial Cell-Culture Processes
The security of obtaining supply for raw materials with the desired profile of contaminants and impurities is one example.
“With raw materials becoming ever more purified, trace levels of impu…
Article
Avoiding Investigational Failures and Discrepancies
Avoiding Investigational Failures and Discrepancies
Investigational failures and discrepancies can be avoided through the proper execution and documentation of investigations.
By Walt Murray,…
Article
From Darwin to Recombinant Fc Multimers
Topics from a Darwinistic viewpoint on how business models are evolving in the Life Science industry to breakthrough research data from Momenta Pharmaceuticals on a recombinant trivalent Fc protein …
Article
Managing Risk in Raw Material Sourcing
Several years ago, Pfizer made supply-chain security practices part of its quality manual, implementing an enterprise-wise scorecard for each supplier (4). J&J has set up supply chain risk monitoring …
Article
Framing Biopharma Success in 2016
Respondents expressed opinions about job security (74.6% feel secure in their current position), seeking new opportunities (59.2% would like to leave their job), and increasing dissatisfaction with sa…
Terms of Use
…se; (b) scan, probe, or test the vulnerability of any system or network or breach or circumvent any security or authentication measures; (c) interfere with, disrupt, or damage the Site or access of a…
Article
Developing oligonucleotide therapeutics with confidence
In this video, we will look at key considerations for oligo therapeutic developers entering the market, such as scalability, flexibility, regulatory concerns, insource/outsource consideratio…
Article
Digitalization: The Route to Biopharma 4.0
… and its acceptance by regulatory agencies; intellectual property rights and information technology security; and probable ways to handle regulatory barriers.
Perspective
The biopharma in…